Medical Devices and Pharma

Medical device and pharmaceutical regulatory consulting and health safety information

FDA and global regulatory affairs, consumer health, and professional development


Expert guidance for industry professionals and clear, reliable information for patients and consumers

Medical Devices
Pharma square image
Biologics Square Image
Combination Products
In Vitro Diagnostics square

Datex-Ohmeda Issues Field Correction for EVair Air Compressors 

Urgent Class I Recall Notice   Datex-Ohmeda Inc. has announced a field correction for its EVair and Jun-air compressors, optional ventilator accessories designed to provide an alternative source of airflow for patient support in clinical settings where wall air is...

Urgent Recall Notice for ARROW QuickFlash Catheterization Kits 

Urgent Recall Notice for ARROW QuickFlash Catheterization Kits  In February 2024, Teleflex and its subsidiary Arrow International issued an urgent recall notice for the ARROW QuickFlash Radial Artery and Radial Artery/Arterial Line Catheterization Kits.   Today, a...

Original FDA Safety Warning for China-made Syringes

In an announcement dated November 30, 2023, the U.S. Food and Drug Administration (FDA) issued a notice regarding the evaluation of potential device failures associated with plastic syringes manufactured in China. The FDA is actively collecting and analyzing data to...

AvKARE Recalls Atovaquone Oral Suspension

AvKARE Recalls Atovaquone Oral Suspension  AvKARE, LLC has issued a voluntary recall of lot # AW0221A of Atovaquone Oral Suspension, USP 750mg/5mL due to potential Bacillus cereus contamination found during stability testing at a third-party lab.   The affected...

QMSR Design Verification and Validation

ISO 13485:2016 Design and Development Clause 7.3 - Design and DevelopmentClause 7.3.1 - GeneralClause 7.3.2 - Design and development planningClause 7.3.3 - Design and development inputsClause 7.3.4 - Design and development outputsClause 7.3.5 - Design and development...

QMSR Design and Development Reviews

ISO 13485:2016  Clause 7.3 - Design and DevelopmentClause 7.3.1 - GeneralClause 7.3.2 - Design and development planningClause 7.3.3 - Design and development inputsClause 7.3.4 - Design and development outputsClause 7.3.5 - Design and development reviewClause 7.3.6 -...

QMSR Design and Development – Design Inputs and Outputs

ISO 13485:2016 Design and Development Clause 7.3 - Design and DevelopmentClause 7.3.1 - GeneralClause 7.3.2 - Design and development planningClause 7.3.3 - Design and development inputsClause 7.3.4 - Design and development outputsClause 7.3.5 - Design and development...

QMSR Design and Development Controls

From Design Control to Design and Development Both the QSR and QMSR have the same design and development phases of planning, inputs, outputs, verification, validation, transfer, and design changes. All of the 21 CFR 820.30 Design Control requirements are covered in...

ICH: The International Council for Harmonization

The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) plays a pivotal role in shaping global pharmaceutical practices, ensuring the quality, safety, and efficacy of medicines worldwide.The International Council...

Regulatory Information Management Systems (RIMS)

What Is a RIMS System?  A Regulatory Information Management (RIM) system is a software solution designed to streamline and automate the management of regulatory information and processes within the life sciences industry, including pharmaceuticals, biotechnology, and...

AvKARE Recalls Atovaquone Oral Suspension

AvKARE Recalls Atovaquone Oral Suspension  AvKARE, LLC has issued a voluntary recall of lot # AW0221A of Atovaquone Oral Suspension, USP 750mg/5mL due to potential Bacillus cereus contamination found during stability testing at a third-party lab.   The affected...

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

FDA Approves New Imaging Drug Lumisight  

A Significant Improvement for Surgical Oncology  The U.S. Food and Drug Administration (FDA) has granted approval to LumiSight (pegulicianine) for use in adults undergoing breast lumpectomy, marking a significant advancement in surgical oncology.   Lumisight, a...

FDA Issues Warning on Counterfeit Botox Products 

Real Botox PackagingReal Botox Cosmetic PackagingReal Botox PackagingCounterfeit Botox Products  The U.S. Food and Drug Administration (FDA) has issued a critical alert concerning the presence of counterfeit Botox products in various states, posing severe risks to...

FDA Approves XACT Carotid Stent System

A Breakthrough for Stroke Prevention  Abbott Vascular Inc. has received FDA approval for its groundbreaking XACT Carotid Stent System, a significant advancement in stroke prevention technology. Approved on February 7, 2024, this innovative system offers new hope for...

FDA Approves Xolremdi for WHIM Syndrome 

A Breakthrough for Rare Infections  In a groundbreaking development, the U.S. Food and Drug Administration (FDA) has granted approval for Xolremdi (mavorixafor) capsules, marking a significant milestone in the treatment of WHIM syndrome. Let's delve into what this...

Global Medical Device Regulation
Global Regulatory
Regulatory Information Management Systems
RIMS Architecture tile square
RIMS for Small and Emerging Businesses
RIMS Readiness Self-Assessment
QMSR Inspections tile
QMSR Implementation Strategies tile
QMSR Terms and Definitions Tile
Affected QMSR regulations and standards tile
QMSR for small manufacturers tile
Medical Device Recalls
Medical Device Warning Letters 1
Pharma Recalls
Pharma Warning Letters
Global Regulatory
Pharma Innovation

Welcome to Medical Devices and Pharma, a website dedicated to providing timely and relevant medical device and pharma information to the regulated medical device and pharmaceutical industries, and consumers of those products.

Our goal is to provide organized, clearly written information from regulatory affairs and consumer perspectives.

  • Key information from the Food and Drug Administration (FDA), the federal regulatory agency responsible for providing oversight over the industries and assuring the safety and efficacy of their products.
  • Regulatory services for compliance, market access, and crisis management
  • Information about innovation, including new products cleared for use in the U.S. market.
  • News stories with topics ranging from product issues to market trends.

Perhaps most importantly, we will strive to maintain vigilance over product issues and their impacts. Check back here for consumer news, product alerts, and current litigation.

Artificial Intelligence

Discover how Artificial Intelligence is revolutionizing the medical device and pharmaceutical industries.

Stay up-to-date with the latest advancements and breakthroughs that are shaping the future of healthcare.

QMSR - Quality Management System Regulation

The U.S. Food and Drug Administration (FDA) has introduced significant updates to its regulatory framework for medical device manufacturers with the transition from the Quality System Regulation (QSR) to the Quality Management System Regulation (QMSR).

This modernization aligns with global standards, streamlining compliance for manufacturers who market devices internationally while maintaining a strong focus on patient safety and product quality.

Quality Management System Regulation - QMSR

Regulatory Information Management Systems - RIMS

Medical Devices
Pharma square image
Combination Products

A veteran-owned business
located in
Iowa’s Cedar Valley